NCT03554447View on ClinicalTrials.gov

Role of Pentoxifylline as an Adjuvant Therapy for Adult Patients With Major Depressive Disorder

NACompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

April 20, 2015

Primary Completion Date

December 1, 2017

Study Completion Date

December 31, 2018

Conditions
Major Depressive Disorder
Interventions
DRUG

Escitalopram 20 mg tablet plus Pentoxifylline 400Mg Tablet

Selective serotonin reuptake inhibitor plus phosphodiesterase inhibitor with anti-inflammatory properties

DRUG

Escitalopram 20 mg tablet + Placebo

Selective serotonin reuptake inhibitor plus placebo

All Listed Sponsors
lead

Mahmoud Samy Abdallah

OTHER

NCT03554447 - Role of Pentoxifylline as an Adjuvant Therapy for Adult Patients With Major Depressive Disorder | Biotech Hunter | Biotech Hunter